NasdaqGS - Nasdaq Real Time Price USD

Embecta Corp. (EMBC)

Compare
12.63 -0.17 (-1.33%)
As of 12:52 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
9/30/2019
Total Revenue
1,132,500.00
1,120,800.00
1,129,500.00
1,165,300.00
1,085,500.00
--
Cost of Revenue
389,900.00
370,900.00
354,600.00
364,900.00
322,900.00
--
Gross Profit
742,600.00
749,900.00
774,900.00
800,400.00
762,600.00
--
Operating Expense
578,300.00
525,900.00
406,400.00
308,400.00
276,100.00
--
Operating Income
164,300.00
224,000.00
368,500.00
492,000.00
486,500.00
--
Net Non Operating Interest Income Expense
-110,100.00
-107,000.00
-46,200.00
--
--
--
Other Income Expense
-4,900.00
-11,300.00
-65,700.00
2,900.00
-700.00
--
Pretax Income
49,300.00
105,700.00
256,600.00
494,900.00
485,800.00
--
Tax Provision
-20,900.00
35,300.00
33,000.00
80,100.00
58,200.00
--
Net Income Common Stockholders
70,200.00
70,400.00
223,600.00
414,800.00
427,600.00
--
Diluted NI Available to Com Stockholders
70,200.00
70,400.00
223,600.00
414,800.00
427,600.00
--
Basic EPS
1.22
1.23
3.92
7.28
7.50
--
Diluted EPS
1.22
1.22
3.89
7.28
7.50
--
Basic Average Shares
57,445.00
57,248.00
57,024.00
57,000.00
57,000.00
--
Diluted Average Shares
57,940.00
57,758.00
57,461.00
57,000.00
57,000.00
--
Total Operating Income as Reported
161,800.00
221,500.00
309,600.00
492,000.00
486,500.00
--
Total Expenses
968,200.00
896,800.00
761,000.00
673,300.00
599,000.00
--
Net Income from Continuing & Discontinued Operation
70,200.00
70,400.00
223,600.00
414,800.00
427,600.00
--
Normalized Income
71,700.00
72,065.00
274,901.90
414,800.00
427,600.00
--
Interest Expense
110,100.00
107,000.00
46,200.00
--
--
--
Net Interest Income
-110,100.00
-107,000.00
-46,200.00
--
--
--
EBIT
159,400.00
212,700.00
302,800.00
494,900.00
485,800.00
--
EBITDA
196,200.00
245,300.00
334,500.00
533,200.00
524,100.00
--
Reconciled Cost of Revenue
389,900.00
370,900.00
354,600.00
364,900.00
322,900.00
--
Reconciled Depreciation
36,800.00
32,600.00
31,700.00
38,300.00
38,300.00
--
Net Income from Continuing Operation Net Minority Interest
70,200.00
70,400.00
223,600.00
414,800.00
427,600.00
--
Total Unusual Items Excluding Goodwill
-2,500.00
-2,500.00
-58,900.00
--
--
--
Total Unusual Items
-2,500.00
-2,500.00
-58,900.00
--
--
--
Normalized EBITDA
198,700.00
247,800.00
393,400.00
533,200.00
524,100.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-1,000.00
-835.00
-7,598.10
--
--
--
9/30/2019 - 3/22/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BDX Becton, Dickinson and Company
232.96
-0.33%
 
ANIK Anika Therapeutics, Inc.
25.96
-1.22%
 
UTMD Utah Medical Products, Inc.
66.76
-0.03%
 
AZTA Azenta, Inc.
54.09
+0.33%
 
LMAT LeMaitre Vascular, Inc.
80.15
+0.08%
 
TGLVY Top Glove Corporation Bhd.
0.9010
+0.11%
 
ATR AptarGroup, Inc.
146.08
+0.92%
 
BAX Baxter International Inc.
33.97
+0.56%
 
COO The Cooper Companies, Inc.
92.55
-0.98%
 
ANGO AngioDynamics, Inc.
5.94
-3.50%